![](https://images.squarespace-cdn.com/content/v1/614c56eef2d7846d13d0d55f/e66197a0-e062-4734-942e-8bdabf030db2/Header3_Large.jpg)
Helping every cancer patient to get the most effective drugs
Aida’s technology can radically improve the effectiveness of prescribed cancer drugs
Only one in four cancer treatments is effective and treatments typically cost more than $10,000 per month.
There are more than 300 cancer drugs available. Each works for some patients to some extent.
![](https://images.squarespace-cdn.com/content/v1/614c56eef2d7846d13d0d55f/4a3aacdf-4b54-4fa4-9790-ef3cb2f81377/Header2_Large.jpg)
Machine-optimized algorithms applied to the RNA expression profile of a patient’s tumor allow us to predict which drugs are most likely to be effective.
More information for doctors
Better outcomes for patients
Better economics for healthcare providers
Meet the Team
-
Ulla Hald Buhl
CEO
-
Peter Buhl Jensen
Medicine
-
Neil Goldsmith
Strategy
-
Claus Pedersen
Finance
-
Andy Gardiner
BD
-
Ida Buhl
Science
-
Eric Barriere
Commercial
-
Noomi Gregersen
Lab Operations
NEWS
27 May 2024
Aida is presenting a poster at ASCO this week. It shows how we have successfully used tumor transcriptome and cell line data to create a test that accurately predicts which cancer patients will respond best to treatment with epirubicin.
This is a significant step in our mission to ensure that every cancer patient gets the most effective drugs.